Search
Search for ‘imaging’ results: 181-194 of 194
-
-
Research Study for Active-Duty Service Members and Veterans with a History of Blast Exposure
Clinical trials -
A phase II multicenter study of lenvatinib plus everolimus versus cabozantinib in patients with metastatic renal cell carcinoma that progressed on a PD-1/PD-L1 checkpoint inhibitor
Clinical trials -
Randomized, multicenter, open-label, phase 3 study of mirvetuximab soravtansine in combination with bevacizumab versus bevacizumab alone as maintenance therapy for patients with FRa–positive recurrent platinum-sensitive epithelial ovarian, fallopian tube, or primary peritoneal cancers who have not progressed after second line platinum-based chemotherapy plus bevacizumab
Clinical trials -
A Phase 3, Randomized, Placebo-Controlled, Double-Blind, Multicenter Trial for Selinexor in Maintenance Therapy after Systemic Therapy for Patients with P53 wild-type, Advanced or Recurrent Endometrial Carcinoma
Clinical trials -
Adults with Recurrent Glioblastoma (GBM) are Invited to Participate in a Research Study
Clinical trials -
Do You Have A History of Ankle Sprains?
Clinical trials -
UVA Health System, Radiology Research: How does air move in the lungs?
Clinical trials -
Would you like to help researchers learn more about a treatment for Crohn’s Disease?
Clinical trials -
Testing the addition of anti-cancer drug, ZEN003694, to the usual chemotherapy treatment, cetuximab plus encorafenib, for colorectal cancer
Clinical trials -
A Research Study for Adult Women with Platinum-Resistant Ovarian, Fallopian Tube or Primary Peritoneal Cancer
Clinical trials -
Testing the use of BRAF-targeted therapy after surgery and usual chemotherapy for BRAF-mutated colon cancer
Clinical trials -
A Phase 3, Randomized, Double-blind, Placebo-controlled, Multicenter Study of Tarlatamab Therapy in Subjects With Limited-Stage Small-Cell Lung Cancer (LS-SCLC) who Have not Progressed Following Concurrent Chemoradiation Therapy (DeLLphi-306)
Clinical trials -
A Phase 1, First-in-Human, Dose Escalation and Expansion Study to Evaluate the Safety and Tolerability of XmAb®541 in Advanced Solid Tumors
Clinical trials